Description
Research Peptide≥99% HPLC StandardShips from Canada
Overview
Selank is a synthetic heptapeptide based on the immune peptide tuftsin, with an added stabilising C-terminal sequence that extends its activity. It is supplied as a stable lyophilized peptide.
In research it is studied for anxiolytic-like and cognitive effects and for neuroimmune signalling, with attention to how it influences neurotransmitter systems and gene expression in the brain. It is offered strictly as a research material, and the study cited below describes preclinical findings only.
Mechanisms of interest in research
GABAergic and monoamine modulation
Selank is studied for effects on inhibitory GABAergic signalling and on monoamine (serotonin, dopamine) systems, changes associated in models with anxiolytic-like and mood-related behaviour.
Neurotrophic and gene-expression effects
It has been examined for influence on the expression of genes involved in neurotransmission and on brain-derived neurotrophic factor, part of its study as a neuroactive peptide.
Tuftsin-derived neuroimmune activity
As a tuftsin analog, Selank also carries immunomodulatory heritage, and its neuroimmune effects are a distinctive focus of research.
Specifications
Selected Research
The following peer-reviewed studies are provided for scientific context on this compound’s research background. They describe preclinical and in-vitro findings only and are not claims about this product.
Selank administration altered the expression of 45 genes involved in neurotransmission within an hour, with changes that correlated with those produced by GABA, indicating modulation of the GABAergic system.
Volkova A, et al. Front Pharmacol. PMID: 26924987
This product is intended exclusively for in-vitro laboratory research. It is not a drug, food, dietary supplement, or cosmetic, and it is not intended for human or veterinary diagnostic, therapeutic, or recreational use.
